2 Minute Medicine

No Result

View All Result

No products in the cart.

Home The 2MM Team

#VisualAbstract GIMEMMA-MMY-3006: Bortezomib, Thalidomide, and Dexamethasone (VTD) Followed By Stem-Cell Transplantation Improves Long-Term Survival Outcomes in Newly Diagnosed Multiple Myeloma (MM)

byKathleen Lau

December 25, 2020

in The 2MM Team

Reading Time: 1 min read

Check out the original article from the Lancet Haematology here.

RELATED REPORTS

Management of Dyspnea With High-Flow Nasal Air or Fan-A Randomized Controlled Crossover Trial

Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial

Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial

Tags: autologous stem cell transplantation blood cancer bortezomib cancer cancer progression chemo chemotherapy dexamethasone double autologous haematopoietic stem-cell transplantation haematopoietic stem cell transplantation hematology hematopoietic cell transplantation Hematopoietic stem-cell transplantation HSCT malignancy MM multiple myeloma myeloma oncology overall survival progression-free survival second primary malignancies stem cell transplant stem cell transplantation survival outcomes thalidomide vtd

COVID-19 susceptibility may be increased in patients with hematological malignancies compared to solid organ tumours

Adding azithromycin to hydroxychloroquine does not improve clinical outcomes in COVID-19 patients

RelatedReports

Chronic Disease

Management of Dyspnea With High-Flow Nasal Air or Fan-A Randomized Controlled Crossover Trial

January 9, 2026

Age and breast cancer risk factors associated with false-positive mammography results

Chronic Disease

Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial

December 29, 2025

Shorter overall survival among patients with monoclonal gammopathy of undetermined significance

Chronic Disease

Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial

December 24, 2025

2 Minute Medicine Rewind March 4, 2019

Chronic Disease

Impact of population based breast density notification: multisite parallel arm randomised controlled trial in BreastScreen

December 10, 2025

Next Post

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Adding azithromycin to hydroxychloroquine does not improve clinical outcomes in COVID-19 patients

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Regular screening of asymptomatic SARS-CoV-2 carriers may limit COVID-19 transmission

Evidence-based interventions for pediatric asthma successfully adapted for community health centers

Use of inhaled corticosteroids is not associated with improved COVID-related mortality in patients with chronic respiratory conditions

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

No Result

View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.